Evercore ISI downgraded Exact Sciences (EXAS) to In Line from Outperform with an unchanged price target of $105.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Exact Sciences Approves Executive Bonus Acceleration Amid Abbott Merger
- Cathie Wood Doubles Down on This Bitcoin ETF, Cuts GitLab Stock (GTLB) Again
- Exact Sciences, Regeneron, Marvell, JFrog, Jazz: Trending by Analysts
- Exact Sciences downgraded to Hold from Buy at Stifel
- Private Markets: Prediction market platform Kalshi secures $300M